Sarah Ketterer - Causeway Capital Management
Holding/activity history for Biogen Inc. (BIIB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 280,783 | 0.63 | Reduce 46.12% | 0.58 | $183.33 | $51,475,885 | SEC |
| 2025 Q4 | 521,101 | 1.26 | Reduce 8.18% | 0.09 | $175.99 | $91,708,545 | SEC |
| 2025 Q3 | 567,518 | 1.05 | Add 15.03% | 0.14 | $140.08 | $79,497,885 | SEC |
| 2025 Q2 | 493,355 | 0.98 | Add 13.80% | 0.12 | $125.59 | $61,960,403 | SEC |
| 2025 Q1 | 433,517 | 1.24 | Add 53.89% | 0.43 | $136.84 | $59,322,464 | SEC |
| 2024 Q4 | 281,702 | 0.98 | Buy | 0.98 | $152.92 | $43,077,910 | SEC |
| 2016 Q4 | 0 | 0.00 | Sell 100.00% | 2.63 | SEC | ||
| 2016 Q3 | 404,444 | 2.63 | Reduce 17.34% | 0.50 | $351.61 | $142,206,000 | SEC |
| 2016 Q2 | 489,263 | 2.91 | Buy | 2.91 | $276.33 | $135,200,000 | SEC |